27th April 2012 - Recipharm Ltd in Ashton under Lyne, UK is pleased to launch a dedicated recovery service for reworking pharmaceutical products under cGMP conditions at its UK site.
This bespoke service is now available following a number of requests from customers and will include:
Data matrix serialization
De-labelling and re-labelling
De-blistering and re-blistering
Unpacking and repackaging
Heat sealing caps
Metal detection in bulk tablet and capsule product.
The facility is fully licensed by the MHRA with on site Qualified Persons and regulatory staff.
We can offer support in making batch specific variations to the Regulatory Authorities.
“Recipharm Ashton’s product recovery team offers rapid, flexible and cost effective solutions that are tried and tested, can avoid costly product re-working in-house, saving time and potentially avoiding write off costs”. Iain Martin, General Manager Recipharm Ltd. commented
Recipharm AB is a leading contract development and manufacturing organization (CDMO) based in Sweden employing some 1700 employees. The Company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain and is headquartered near Stockholm. Recipharm supplies the global pharmaceuticals market with hundreds of different products in multiple dosage forms that include solid dose, granulates and powders, sterile liquids and lyophilisates, semi solids, beta-lactams, hormones, oral liquids, sprays and dry powder inhalers. For more information visit; www.recipharm.com
Dewi Lewis, E-mail : email@example.com, Tel :+44 (0) 161 342 6433
For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on:
E-mail: firstname.lastname@example.org or email@example.com
Tel: +44 (0) 207 861 3019/3043